Table 2.
In vivo evidence of neuroprotective activities of LAB as probiotics.
Main Author, Year | LAB/Probiotic Formulation Containing LAB | Animal | Activities/Results | Ref. |
---|---|---|---|---|
Azm et al., 2018 |
Lactobacillus acidophilus (1688FL431-16LA02) Lactobacillus fermentum (ME3) Bifidobacterium lactis (1195SL609-16BS01) Bifidobacterium longum (1152SL593-16BL03) |
Eight-week-old male Wistar rats Aβ-induced Alzheimer’s disease (AD) model |
Significant improvement in spatial memory in rats. Improved oxidative stress biomarkers. |
[59] |
Bonfili et al., 2018 | Formulation SLAB51: Lactobacillus acidophilus DSM 32241 Lactobacillus helveticus DSM 32242 Lactobacillus paracasei DSM 32243 Lactobacillus plantarum DSM 32244 Lactobacillus brevis DSM 27961 Bifidobacterium lactis DSM 32246 Bifidobacterium lactis DSM 32247 Streptococcus thermophilus DSM 32245 |
Eight-week-old male transgenic Alzheimer’s disease (AD) mice (3xTg-AD) | Significantly reduced oxidative stress in AD mice brain by activating SIRT1-dependent mechanisms. | [62] |
Corpuz et al., 2018 |
Lactobacillus paracasei K71 Lactobacillus casei subsp. Casei zz |
Fourteen-week-old female SAMP8 mice | Better cognitive performance in the Barnes maze and passive avoidance tests after K71 supplementation. Upregulation in BDNF expression and CREB phosphorylation in the hippocampus. |
[53] |
Choi et al., 2019 | Lactobacillus plantarum | Seven-week-old male C57BL/6J mice | Reduced depression-like behavior by elevating BDNF expression. | [56] |
Rezaei Asl et al., 2019 |
Lactobacillus acidophilus
Bifidobacterium bifidum Bifidobacterium longum |
Adult male Wistar rats Aβ-induced Alzheimer’s disease (AD) model | Improved maze navigation. Restored long-term potentiation (LTP) in rats. |
[60] |
Rezaeiasl et al., 2019 |
Lactobacillus acidophilus
Bifidobacterium bifidum Bifidobacterium longum |
Adult male Wistar rats Aβ-induced Alzheimer’s disease (AD) model | Significant improvement in learning. Increased paired-pulse facilitation (PPF) ratios. |
[61] |
Bonfili et al., 2020 | Formulation SLAB51: Lactobacillus acidophilus DSM 32241 Lactobacillus helveticus DSM 32242 Lactobacillus paracasei DSM 32243 Lactobacillus plantarum DSM 32244 Lactobacillus brevis DSM 27961 Bifidobacterium lactis DSM 32246 Bifidobacterium lactis DSM 32247 Streptococcus thermophilus DSM 32245 |
Eight-week-old male transgenic Alzheimer’s disease (AD) mice (3xTg-AD) | Improvement in glucose uptake in the brain. Memory improvement. |
[63] |
Mehrabadi and Sadr, 2020 |
Lactobacillus reuteri
Lacticaseibacillus rhamnosus Bifidobacterium infantis |
Male Wistar rats, Aβ1-40-induced Alzheimer’s disease (AD) model | Significant improvement in spatial memory and reduced Aβ plaques. Reduced IL-1β and TNF-α inflammation markers. |
[65] |
Kaur et al., 2020 | VSL#3® Formulation: Lactobacillus acidophilus Lactobacillus plantarum Lactobacillus paracasei Lactobacillus delbrueckii subsp. bulgaricus Streptococcus thermophilus Bifidobacterium longum Bifidobacterium breve Bifidobacterium infantis |
C57BL/6 wild-type (WT) AppNL-G-F mice, Alzheimer’s disease (AD) model |
Altered levels of lactate and acetate in both serum and brain. Upregulated expression of the neuronal activity marker, c-Fos. |
[64] |
Visnuk et al., 2020 |
Lactobacillus plantarum CRL 2130 (a riboflavin producer) Streptococcus thermophilus CRL 807 (an immunomodulatory strain) Streptococcus thermophilus CRL 808 (a folate producer) |
Eight-week-old male C57BL/6 mice (MPTP/probenecid parkinsonism model) | Enhanced motor skills. Higher brain tyrosine-hydrolase-positive cell counts. Reduced IL-6 and TNF-α in serum. Elevated levels of IL-10 in serum and brain tissues. Improvement in neuroinflammation. |
[43] |
Yang et al., 2020 | ProBiotic-4 formulation: Lactobacillus casei Lactobacillus acidophilus Bifidobacterium lactis Bifidobacterium bifidum |
Nine-month-old senescence-accelerated mouse prone 8 (SAMP8) | Improved the memory deficits, cerebral neuronal and synaptic injuries, glial activation, and microbiota composition in the feces and brains. | [55] |
Beltagy et al., 2021 | Lactobacillus acidophilus | Adult male albino rats (6–7 weeks age) | Significant changes in neurotransmitters and antioxidants levels. Alleviate learning- and memory-associated injuries in Alzheimer’s rats. |
[58] |
Wang et al., 2021 | Lactobacillus plantarum DP189 | MPTP-induced Parkinson’s disease (PD) model mice | Improved behavioral ability. Significant neuroprotective effect in PD mice. |
[66] |
Zolfaghari et al., 2021 |
Lacticaseibacillus rhamnosus
Lactobacillus reuteri Lactobacillus plantarum |
Adult male Wistar rats | Prevented LPS-induced elevation of TNF-α mRNA and memory deterioration. Probiotics exert neuroprotective activity via immune-modulatory properties. |
[57] |
Liu et al., 2022 | Lacticaseibacillus rhamnosus GG | Male C57BL/6J mice (8-week-old) | Prevented dopaminergic neuronal loss and weakened muscle strength in behavior tests. Neuroprotective activities possibly due to enhancement of striatal glial-cell-derived neurotrophic factor (GDNF) expression. |
[67] |
Sahin et al., 2022 | VSL#3® Formulation: Lactobacillus acidophilus Lactobacillus plantarum Lactobacillus paracasei Lactobacillus delbrueckii subsp. bulgaricus Streptococcus thermophilus Bifidobacterium longum Bifidobacterium breve Bifidobacterium infantis |
Eight-week-old Wistar Albino rats | Decreased oxidative stress and inflammatory markers. Reduced neurotoxic effects of aflatoxin B1 in rats. |
[54] |
Visnuk et al., 2022 |
Lactiplantibacillus plantarum CRL2130 Lactiplantibacillus plantarum CRL725 |
Eight-week-old male C57BL/6 mice (MPTP/probenecid parkinsonism model) | Attenuated motor deficits Prevented dopaminergic neuronal death. Decreased pro-inflammatory cytokines and increase in IL-10 levels in serum and brain |
[42] |